Consulting

Competitive Intelligence

Stay ahead of an evolving competitive landscape with insight-led consulting. We analyze competitors, pipelines, and strategic intent to help you anticipate market moves, pressure-test assumptions, and identify areas of differentiation.

Why choose Evaluate?

Data-Driven Foundation

Access to Norstella-wide data and insights

Flexible Engagements

Leverage proprietary AI solutions built on trusted Norstella data

Try Us First

Low friction opportunities to partner with our team and test our capabilities to build your business case

Flexible Program Options

Tailored programs aligned to your investment goals from streamlined monitoring programs to all-in strategic support and business implications

Competition in biopharma is fierce.

Evaluate’s CI practice provides clinical and commercial teams with support to understand their evolving competitive landscape and to facilitate strategic decision making.

We help with:

  • Competitor and market insights

  • Competitor monitoring

  • Customized dashboards and analytics

  • Strategic workshops and recommendations

Competitive Intelligence Services

End-to-end insight from the conferences that shape your competitive landscape.

Whether you need streamlined virtual support or fully immersive on-the-ground intelligence, our team delivers clarity, context, and confidence at every step throughout the conference coverage journey. Partner with us to ensure your organization stays informed and ready to capitalize on market-shaping updates.

Questions we help to answer:

  • Which conferences are most critical for us this year?

  • How do we ensure complete capture of all important updates across conferences of interest?

  • Which presentations moved the needle? What does that mean for us?

  • Would real-time updates support leadership questions and help us respond faster?

Cut through the noise. Stay ahead of every meaningful competitive update.

Whether you need recurring newsletters or rapid, same day alerts, our consultants help you cut through noise, anticipate risk, and respond with confidence, keeping your organization poised to act in a fast-moving market.

Questions we help to answer:

  • How can we strengthen the way we monitor and prioritize competitive updates, ensuring mission-critical signals are not missed?

  • How do we reliably translate raw updates into clear, actionable business implications?

  • How can same-day alerts or curated newsletters help us respond faster and stay ahead of leadership expectations?

A complete, strategic narrative of the competitors shaping your future.

Whether profiling five competitors or 20, our team delivers clear, strategic, and actionable intelligence that empowers confident decision-making across your organization.

Questions we help to answer:

  • How can we access a single, consistent, and reliable view of competitor strategy?

  • How can we provide leadership with a concise narrative of our key competitors?

  • How can we proactively understand and prepare for a competitor’s future threat level?

Have a bespoke requirement?

Every strategic challenge is different. If you need to answer a unique commercial question or require tailored support beyond standard solutions, our consulting team will work with you to design an approach that fits your objectives, timelines, and data needs.

Consultant perspectives, on demand

Hear directly from our consulting experts on how we work with clients, approach complex challenges, and deliver insight‑led support across the commercial lifecycle.

Meet your BD consultants

Our experts will help you identify the tools and insights that support your strategic, commercial, or investment priorities.

Ben Folwell, PhD

Director & Business Development & Licensing Lead

Ben specializes in quantitative analysis, leading projects covering buy and sell side due diligence, deal benchmarking, pipeline tracking, competitor analysis and product forecasting across a broad range of indications and markets, with an increasing focus on rare diseases. Recent work has included building prioritization models that can be used to identify in-licensing opportunities, out licensing partners, attractive indications, or technologies.​ Ben has authored multiple peer-reviewed journal articles and industry standard guideline documents.

Paul Verdin, PhD

Senior Vice President and Head of Consulting & Analytics

Paul leads the Evaluate’s consulting and analytics business, overseeing strategic advisory engagements across portfolio strategy, asset strategy, competitive intelligence, forecasting, valuation, and BD&L, working with clients across the global pharma and biotech ecosystem.

Paul brings extensive experience spanning academic research and life sciences consulting, supporting organizations ranging from early-stage biotech companies to large pharmaceutical corporate strategy teams. His work focuses on helping clients make evidence-based decisions across the product lifecycle, from pipeline prioritization through to commercial strategy and investment decision-making.

Latest Resources

Ready to see how Evaluate can help you make smarter decisions?

Get in touch with our team to explore the right solutions for your business.